Rafferty Asset Management, LLC Ardelyx, Inc. Transaction History

Rafferty Asset Management, LLC

$29.7 Billion
Q3 2025

A detailed history of Rafferty Asset Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 314,781 shares of ARDX stock, worth $1.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

314,781

Previous 359,499 12.44%

Holding current value

$1.85 Million

Previous $1.41 Million 23.28%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$3.92 - $6.64 $175,294 - $296,927	-44,718 Reduced 12.44%	314,781 $1.74 Million
Q2 2025 Aug 14, 2025	SELL	$3.28 - $5.51 $111,287 - $186,948	-33,929 Reduced 8.62%	359,499 $1.41 Million
Q1 2025 May 14, 2025	SELL	$4.91 - $6.36 $693,856 - $898,763	-141,315 Reduced 26.43%	393,428 $1.93 Million
Q4 2024 Feb 14, 2025	SELL	$4.49 - $6.85 $268,106 - $409,027	-59,712 Reduced 10.04%	534,743 $2.76 Million
Q3 2024 Nov 13, 2024	SELL	$5.28 - $7.57 $254,791 - $365,297	-48,256 Reduced 7.51%	594,455 $4.1 Million

Q2 2024 Aug 13, 2024	SELL	$5.89 - $9.31 $2.43 Million - $3.84 Million	-412,582 Reduced 39.1%	642,711 $4.76 Million
Q1 2024 May 13, 2024	SELL	$6.05 - $9.74 $1.94 Million - $3.12 Million	-320,221 Reduced 23.28%	1,055,293 $7.7 Million
Q4 2023 Feb 13, 2024	BUY	$3.29 - $6.64 $913,369 - $1.84 Million	277,620 Added 25.29%	1,375,514 $8.53 Million
Q3 2023 Nov 13, 2023	SELL	$3.3 - $4.83 $3.26 Million - $4.78 Million	-989,230 Reduced 47.4%	1,097,894 $4.48 Million
Q2 2023 Aug 11, 2023	BUY	$3.23 - $4.95 $1.74 Million - $2.67 Million	538,992 Added 34.82%	2,087,124 $7.08 Million
Q1 2023 May 11, 2023	BUY	$2.68 - $4.79 $4.15 Million - $7.42 Million	1,548,132 New	1,548,132 $7.42 Million
Q3 2021 Nov 10, 2021	SELL	$1.27 - $8.17 $354,780 - $2.28 Million	-279,355 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$6.55 - $8.98 $738,597 - $1.01 Million	112,763 Added 67.69%	279,355 $2.12 Million
Q1 2021 May 10, 2021	BUY	$6.1 - $7.69 $915,707 - $1.15 Million	150,116 Added 911.12%	166,592 $1.1 Million
Q4 2020 Feb 10, 2021	SELL	$5.05 - $7.1 $202,934 - $285,313	-40,185 Reduced 70.92%	16,476 $107,000
Q3 2020 Nov 13, 2020	BUY	$5.25 - $7.08 $137,292 - $185,149	26,151 Added 85.71%	56,661 $297,000
Q2 2020 Aug 07, 2020	BUY	$5.37 - $8.11 $163,838 - $247,436	30,510 New	30,510 $211,000

Others Institutions Holding ARDX

# of Institutions

244

Shares Held

160M

Call Options Held

697K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Ardelyx, Inc. Transaction History